Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Benralizumab in Chronic Obstructive Pulmonary Disease (COPD)
NCT05273359Phase 2Unknown
- Sponsor
- Temple University
- Start
- Apr 2023
- Primary completion
- Jun 2024
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 2 trial of benralizumab in chronic obstructive pulmonary disease (COPD), sponsored by Temple University. Status: unknown.
02
Drugs
benralizumab
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05273359.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05273359.